Up to 80% of athletes who die suddenly had no symptoms or family history of heart disease
Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe exercise are published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).
Genetic testing for potentially lethal variants is more accessible than ever before and this document focuses on which athletes should be tested and when,” said author Dr. Michael Papadakis of St George’s, University of London, UK. “Sportspeople should be counselled on the potential outcomes prior to genetic testing since it could mean exclusion or restricted play.”
In most cases, clinical evaluation will dictate the need for preventive therapy such as a defibrillator and the advice on exercise and participation in competitive sports. Dr. Papadakis explained:
Even if a genetic abnormality is found, recommendations on treatment and return to play usually depend on how severe the disease is clinically. Is it causing symptoms such as fainting? Is ......
Esta publicación es para usuarios registrados
Please register or log in with your account to read the full publication.